We use cookies on accura.dk

accura.dk uses cookies to improve the user-friendliness and functionality. By using our website, you consent to our use of cookies. Read more about cookies at accura.dk. Enjoy.

Read more about our cookie policy and instructions to delete cookies


Accura assists EQT with acquisition of Fertin Pharma A/S


Accura has advised EQT on the acquisition of Fertin Pharma A/S (Fertin), the world's largest B2B manufacturer of medicated chewing gum having nicotine gum (Nicotine Replacement Therapy – NRT) as their largest product category. Fertin also develops other medicated chewing gum products.

Fertin employs 715 people and was founded by the Bagger-Sørensen family. The 2016 annual revenue is estimated at DKK 851m.

The Bagger-Sørensen family will reinvest and enter a partnership with EQT to continue the development of Fertin and accelerate growth in the company.

Thomas Weincke, Kim Toftgaard and Kristian Lykkeholm Klausen advised EQT.



Thomas Weincke
Thomas Weincke

Partner, Attorney-at-Law

Mobile: +45 3078 6678